Sex-specific effects of PNPLA3 I148M.

Area of Science:

• Hepatology
• Genetics
• Metabolic Diseases

Background:

• Metabolic dysfunction-associated steatotic liver disease (MASLD) is more prevalent and severe in men.
• Sex differences in MASLD are influenced by genetic, hormonal, environmental, and lifestyle factors.
• Oestrogen signalling and the PNPLA3 I148M variant are implicated in MASLD's sexual dimorphism.

Purpose of the Study:

• To investigate the molecular mechanisms behind the sex-specific role of the PNPLA3 I148M variant in MASLD.
• To understand how PNPLA3 influences lipid metabolism and MASLD development differently in males and females.

Main Methods:

• Utilizing in vitro, ex vivo, and in vivo models.
• Analyzing the function of the PNPLA3 gene and its I148M variant in lipid metabolism.
• Comparing disease development and progression across different sexes and genetic backgrounds.

Main Results:

• The PNPLA3 I148M variant is a significant risk factor for MASLD, particularly in women.
• This variant is strongly associated with increased liver fat content and disease severity.
• Evidence suggests a crucial role for PNPLA3 in the sex-specific pathogenesis of MASLD.

Conclusions:

• The PNPLA3 I148M variant contributes to MASLD sex differences, with a notable impact on women's risk and severity.
• Further research using developed models is crucial to fully elucidate these sex-specific molecular mechanisms.
• Understanding these differences is key to developing targeted MASLD therapies.